Role of Mitochondrial Aldehyde Dehydrogenase in Nitrate Tolerance
- 1 November 2003
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 64 (5) , 1109-1116
- https://doi.org/10.1124/mol.64.5.1109
Abstract
Glyceryl trinitrate (GTN) is used in the treatment of angina pectoris and cardiac failure, but the rapid onset of GTN tolerance limits its clinical utility. Research suggests that a principal cause of tolerance is inhibition of an enzyme responsible for the production of physiologically active concentrations of NO from GTN. This enzyme has not conclusively been identified. However, the mitochondrial aldehyde dehydrogenase (ALDH2) is inhibited in GTN-tolerant tissues and produces from GTN, which is proposed to be converted to NO within mitochondria. To investigate the role of this enzyme in GTN tolerance, cumulative GTN concentration-response curves were obtained for both GTN-tolerant and -nontolerant rat aortic rings treated with the ALDH inhibitor cyanamide or the ALDH substrate propionaldehyde. Tolerance to GTN was induced using both in vivo and in vitro protocols. The in vivo protocol resulted in almost complete inhibition of ALDH2 activity and GTN biotransformation in hepatic mitochondria, indicating that long-term GTN exposure results in inactivation of the enzyme. Treatment with cyanamide or propionaldehyde caused a dose-dependent increase in the EC50 value for GTN-induced relaxation of similar magnitude in both tolerant and nontolerant aorta, suggesting that although cyanamide and propionaldehyde inhibit GTN-induced vasodilation, these inhibitors do not affect the enzyme or system involved in tolerance development to GTN. Treatment with cyanamide or propionaldehyde did not significantly inhibit 1,1-diethyl-2-hydroxy-2-nitrosohydrazine-mediated vasodilation in tolerant or nontolerant aorta, indicating that these ALDH inhibitors do not affect the downstream effectors of NO-induced vasodilation. Immunoblot analysis indicated that the majority of vascular ALDH2 is present in the cytoplasm, suggesting that mitochondrial biotransformation of GTN by ALDH2 plays a minor role in the overall vascular biotransformation of GTN by this enzyme.Keywords
This publication has 47 references indexed in Scilit:
- Identification of the enzymatic mechanism of nitroglycerin bioactivationProceedings of the National Academy of Sciences, 2002
- In Vitro Activation of Soluble Guanylyl Cyclase and Nitric Oxide Release: A Comparison of NO Donors and NO MimeticsBiochemistry, 2001
- Tolerance induction by transdermal glyceryl trinitrate in ratsEuropean Journal of Pharmacology, 1999
- Inhibition of chicken liver carboxylesterase by activated carbonyls and carbonyl hydratesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1996
- Reactivity of thionitrate esters: putative intermediates in nitrovasodilator activityChemical Communications, 1996
- Biotransformation of organic nitrates and vascular smooth muscle cell functionTrends in Pharmacological Sciences, 1994
- Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerinThe American Journal of Cardiology, 1991
- Effect of in vitro organic nitrate tolerance on relaxation, cyclic GMP accumulation, and guanylate cyclase activation by glyceryl trinitrate and the enantiomers of isoidide dinitrate.Circulation Research, 1988
- How does nitroglycerin induce vascular smooth muscle relaxation?Trends in Pharmacological Sciences, 1984
- Reactions of nitric oxide with cytochrome c oxidaseBiochemistry, 1980